Correlation Between Pharmaceuticals Ultrasector and Biotechnology Ultrasector
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Biotechnology Ultrasector.
Diversification Opportunities for Pharmaceuticals Ultrasector and Biotechnology Ultrasector
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pharmaceuticals and Biotechnology is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Biotechnology Ultrasector go up and down completely randomly.
Pair Corralation between Pharmaceuticals Ultrasector and Biotechnology Ultrasector
Assuming the 90 days horizon Pharmaceuticals Ultrasector is expected to generate 1.32 times less return on investment than Biotechnology Ultrasector. But when comparing it to its historical volatility, Pharmaceuticals Ultrasector Profund is 1.38 times less risky than Biotechnology Ultrasector. It trades about 0.1 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 3,560 in Biotechnology Ultrasector Profund on April 22, 2025 and sell it today you would earn a total of 533.00 from holding Biotechnology Ultrasector Profund or generate 14.97% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Pharmaceuticals Ultrasector Pr vs. Biotechnology Ultrasector Prof
Performance |
Timeline |
Pharmaceuticals Ultrasector |
Biotechnology Ultrasector |
Pharmaceuticals Ultrasector and Biotechnology Ultrasector Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pharmaceuticals Ultrasector and Biotechnology Ultrasector
The main advantage of trading using opposite Pharmaceuticals Ultrasector and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.The idea behind Pharmaceuticals Ultrasector Profund and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |